218 related articles for article (PubMed ID: 26951512)
1. Insight into the molecular basis of Schistosoma haematobium-induced bladder cancer through urine proteomics.
Bernardo C; Cunha MC; Santos JH; da Costa JM; Brindley PJ; Lopes C; Amado F; Ferreira R; Vitorino R; Santos LL
Tumour Biol; 2016 Aug; 37(8):11279-87. PubMed ID: 26951512
[TBL] [Abstract][Full Text] [Related]
2. Estrogen-like metabolites and DNA-adducts in urogenital schistosomiasis-associated bladder cancer.
Gouveia MJ; Santos J; Brindley PJ; Rinaldi G; Lopes C; Santos LL; da Costa JM; Vale N
Cancer Lett; 2015 Apr; 359(2):226-32. PubMed ID: 25615421
[TBL] [Abstract][Full Text] [Related]
3. The role of estradiol metabolism in urogenital schistosomiasis-induced bladder cancer.
Vale N; Gouveia MJ; Rinaldi G; Santos J; Santos LL; Brindley PJ; da Costa JM
Tumour Biol; 2017 Mar; 39(3):1010428317692247. PubMed ID: 28345469
[TBL] [Abstract][Full Text] [Related]
4. Estrogen receptors in urogenital schistosomiasis and bladder cancer: Estrogen receptor alpha-mediated cell proliferation.
Bernardo C; Santos J; Costa C; Tavares A; Amaro T; Marques I; Gouveia MJ; Félix V; Afreixo V; Brindley PJ; Costa JM; Amado F; Helguero L; Santos LL
Urol Oncol; 2020 Sep; 38(9):738.e23-738.e35. PubMed ID: 32507545
[TBL] [Abstract][Full Text] [Related]
5. P53 and cancer-associated sialylated glycans are surrogate markers of cancerization of the bladder associated with Schistosoma haematobium infection.
Santos J; Fernandes E; Ferreira JA; Lima L; Tavares A; Peixoto A; Parreira B; Correia da Costa JM; Brindley PJ; Lopes C; Santos LL
PLoS Negl Trop Dis; 2014 Dec; 8(12):e3329. PubMed ID: 25502795
[TBL] [Abstract][Full Text] [Related]
6. [Urinary schistosomiasis and cancer].
Berry A; Iriart X; Fillaux J; Magnaval JF
Bull Soc Pathol Exot; 2017 Feb; 110(1):68-75. PubMed ID: 28185084
[TBL] [Abstract][Full Text] [Related]
7. Angiogenesis in Schistosoma haematobium-associated urinary bladder cancer.
Dematei A; Fernandes R; Soares R; Alves H; Richter J; Botelho MC
APMIS; 2017 Dec; 125(12):1056-1062. PubMed ID: 28960560
[TBL] [Abstract][Full Text] [Related]
8. [Urothelial carcinoma associated with parasitization by Schistosoma haematobium].
García-Lozano T; Machado Puerto I; Collado Serra A; Aznar Oroval E
Rev Clin Esp (Barc); 2013 Apr; 213(3):e27-8. PubMed ID: 23177375
[No Abstract] [Full Text] [Related]
9. The incidence of squamous and transitional cell carcinomas of the urinary bladder in northern Tanzania in areas of high and low levels of endemic Schistosoma haematobium infection.
Kitinya JN; Laurèn PA; Eshleman LJ; Paljärvi L; Tanaka K
Trans R Soc Trop Med Hyg; 1986; 80(6):935-9. PubMed ID: 3111028
[TBL] [Abstract][Full Text] [Related]
10. Targeting molecular signaling pathways of Schistosoma haemotobium infection in bladder cancer.
Botelho MC; Machado JC; Brindley PJ; Correia da Costa JM
Virulence; 2011; 2(4):267-79. PubMed ID: 21788729
[TBL] [Abstract][Full Text] [Related]
11. Schistosoma haematobium egg-induced bladder urothelial abnormalities dependent on p53 are modulated by host sex.
Honeycutt J; Hammam O; Hsieh MH
Exp Parasitol; 2015 Nov; 158():55-60. PubMed ID: 26160678
[TBL] [Abstract][Full Text] [Related]
12. Nitrative DNA damage and Oct3/4 expression in urinary bladder cancer with Schistosoma haematobium infection.
Ma N; Thanan R; Kobayashi H; Hammam O; Wishahi M; El Leithy T; Hiraku Y; Amro el-K; Oikawa S; Ohnishi S; Murata M; Kawanishi S
Biochem Biophys Res Commun; 2011 Oct; 414(2):344-9. PubMed ID: 21951846
[TBL] [Abstract][Full Text] [Related]
13. Host tissue proteomics reveal insights into the molecular basis of Schistosoma haematobium-induced bladder pathology.
Osakunor DNM; Ishida K; Lamanna OK; Rossi M; Dwomoh L; Hsieh MH
PLoS Negl Trop Dis; 2022 Feb; 16(2):e0010176. PubMed ID: 35167594
[TBL] [Abstract][Full Text] [Related]
14. Controversies and challenges in research on urogenital schistosomiasis-associated bladder cancer.
Honeycutt J; Hammam O; Fu CL; Hsieh MH
Trends Parasitol; 2014 Jul; 30(7):324-32. PubMed ID: 24913983
[TBL] [Abstract][Full Text] [Related]
15. Detection of cytological abnormalities in urothelial cells from individuals previously exposed or currently infected with Schistosoma haematobium.
Smith-Togobo C; Mprah R; Yeboah EA; Anyidoho HK; Asigbe D; Afernorfe JK; Ayroe F; Duedu KO
PLoS One; 2023; 18(3):e0278202. PubMed ID: 36996097
[TBL] [Abstract][Full Text] [Related]
16. Patterns of Schistosoma haematobium egg distribution in the human lower urinary tract. III. Cancerous lower urinary tracts.
Christie JD; Crouse D; Kelada AS; Anis-Ishak E; Smith JH; Kamel IA
Am J Trop Med Hyg; 1986 Jul; 35(4):759-64. PubMed ID: 3089035
[TBL] [Abstract][Full Text] [Related]
17. Tumor markers of bladder cancer: the schistosomal bladder tumors versus non-schistosomal bladder tumors.
Abdulamir AS; Hafidh RR; Kadhim HS; Abubakar F
J Exp Clin Cancer Res; 2009 Feb; 28(1):27. PubMed ID: 19243595
[TBL] [Abstract][Full Text] [Related]
18. Development of Urinary Bladder Pre-Neoplasia by
Chala B; Choi MH; Moon KC; Kim HS; Kwak C; Hong ST
Korean J Parasitol; 2017 Feb; 55(1):21-29. PubMed ID: 28285503
[No Abstract] [Full Text] [Related]
19. Schistosomiasis-induced squamous cell bladder carcinoma in an HIV-infected patient.
Marbjerg LH; Øvrehus AL; Johansen IS
Int J Infect Dis; 2015 Nov; 40():113-5. PubMed ID: 26474894
[TBL] [Abstract][Full Text] [Related]
20. Relationship between bladder cancer incidence, Schistosoma haematobium infection, and geographical region in Zimbabwe.
Thomas JE; Bassett MT; Sigola LB; Taylor P
Trans R Soc Trop Med Hyg; 1990; 84(4):551-3. PubMed ID: 2128668
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
